| 1/3 | US=90 / Câncer Thompson J, Stewart CF, Houghton PJ. Models for studying the action of topoisomerase-I targeted drugs. In: Teicher BA. Tumor models in cancer research. New Jersey: Humana press, 2002. p. 541-63. MODELOS DE TUMORES DOS ROEDORES; MODELOS XENOENXERTO HUMANO; ATIVIDADE ANTITUMORAL; MODELOS DE RESISTENCIA; TOXICIDADE; TOXICIDADE GASTROINTESTINAL; MODELOS DE CAMUNDONGOS; MODELOS DE RATOS; MODELOS HAMSTER |
| 2/3 | US=23-B / Câncer Peng Z, Xie K. Gastric cancer: antitumor activity of RUNX3. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 153-62. ISBN 978-1-4020-8899-5. CANCER; CANCER GASTROINTESTINAL; CANCER GASTRICO; ATIVIDADE ANTITUMORAL; RUNX3 |
| 3/3 | US=55 / Biol/Mol Gourdeau H, Jolivet J. Troxacitabine (troxatyl): a deoxycytidine nucleside analog with potent antitumor activity. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 199-214. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. TROXACITABINE; TROXATYL; ANALOGO NUCLESIDE DEOXICITIDINE; ATIVIDADE ANTITUMORAL; QUIMIOTERAPIA; TRATAMENTO CLINICO; NEOPLASIAS HEMATOLOGICAS; TUMORES SOLIDOS |